Clinical trial
Large Simple Trial (LST) Of Cardiovascular Safety Of Ziprasidone And Olanzapine…
NCT00418171 · Pfizer, Industry · Completed
Key facts
| NCT number | NCT00418171 |
|---|---|
| Title | Large Simple Trial (LST) Of Cardiovascular Safety Of Ziprasidone And Olanzapine- (Zodiac) |
| Official title | An International, Multicenter, Large Simple Trial (LST) To Compare The Cardiovascular Safety Of Ziprasidone And Olanzapine |
| Lead sponsor | Pfizer, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Schizophrenia |
| Intervention type | Drug |
| Interventions | Ziprasidone, Olanzapine |
| Enrollment | 18,239 |
| Start date | Feb 1, 2002 |
| Completion | Apr 1, 2007 |
| First posted | Jan 4, 2007 |
| Last update posted | Oct 26, 2009 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: